BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 30288023)

  • 1. Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a review.
    Sova M; Saso L
    Drug Des Devel Ther; 2018; 12():3181-3197. PubMed ID: 30288023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals.
    Surh YJ; Kundu JK; Na HK
    Planta Med; 2008 Oct; 74(13):1526-39. PubMed ID: 18937164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents.
    Giudice A; Arra C; Turco MC
    Methods Mol Biol; 2010; 647():37-74. PubMed ID: 20694660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers.
    Kwak MK; Wakabayashi N; Kensler TW
    Mutat Res; 2004 Nov; 555(1-2):133-48. PubMed ID: 15476857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting NRF2 signaling for cancer chemoprevention.
    Kwak MK; Kensler TW
    Toxicol Appl Pharmacol; 2010 Apr; 244(1):66-76. PubMed ID: 19732782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemopreventive promise of targeting the Nrf2 pathway.
    Yates MS; Kensler TW
    Drug News Perspect; 2007 Mar; 20(2):109-17. PubMed ID: 17440634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2 as a target for cancer chemoprevention.
    Yu X; Kensler T
    Mutat Res; 2005 Dec; 591(1-2):93-102. PubMed ID: 16054659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway.
    Hayes JD; McMahon M; Chowdhry S; Dinkova-Kostova AT
    Antioxid Redox Signal; 2010 Dec; 13(11):1713-48. PubMed ID: 20446772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dithiolethiones: a privileged pharmacophore for anticancer therapy and chemoprevention.
    Ansari MI; Khan MM; Saquib M; Khatoon S; Hussain MK
    Future Med Chem; 2018 May; 10(10):1241-1260. PubMed ID: 29749746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nrf2 as a chemoprevention target in gastrointestinal carcinoma].
    Gao P; Tang XW; Wang XJ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 41(4):453-63. PubMed ID: 22927084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression.
    Lee JH; Khor TO; Shu L; Su ZY; Fuentes F; Kong AN
    Pharmacol Ther; 2013 Feb; 137(2):153-71. PubMed ID: 23041058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults.
    Osburn WO; Kensler TW
    Mutat Res; 2008; 659(1-2):31-9. PubMed ID: 18164232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrf2-ARE signaling pathway and natural products for cancer chemoprevention.
    Zhao CR; Gao ZH; Qu XJ
    Cancer Epidemiol; 2010 Oct; 34(5):523-33. PubMed ID: 20638930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2: a potential molecular target for cancer chemoprevention by natural compounds.
    Jeong WS; Jun M; Kong AN
    Antioxid Redox Signal; 2006; 8(1-2):99-106. PubMed ID: 16487042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs.
    Telkoparan-Akillilar P; Suzen S; Saso L
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31022969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention.
    Giudice A; Montella M
    Bioessays; 2006 Feb; 28(2):169-81. PubMed ID: 16435293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells.
    Nair S; Li W; Kong AN
    Acta Pharmacol Sin; 2007 Apr; 28(4):459-72. PubMed ID: 17376285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward an understanding of the role of a catechol moiety in cancer chemoprevention: The case of copper- and o-quinone-dependent Nrf2 activation by a catechol-type resveratrol analog.
    Lin D; Dai F; Sun LD; Zhou B
    Mol Nutr Food Res; 2015 Dec; 59(12):2395-406. PubMed ID: 26314862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics, pharmacogenomics and epigenetics of Nrf2-regulated xenobiotic-metabolizing enzymes and transporters by dietary phytochemical and cancer chemoprevention.
    Wu TY; Khor TO; Lee JH; Cheung KL; Shu L; Chen C; Kong AN
    Curr Drug Metab; 2013 Jul; 14(6):688-94. PubMed ID: 23869812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticarcinogenesis by dietary phytochemicals: cytoprotection by Nrf2 in normal cells and cytotoxicity by modulation of transcription factors NF-kappa B and AP-1 in abnormal cancer cells.
    Gopalakrishnan A; Tony Kong AN
    Food Chem Toxicol; 2008 Apr; 46(4):1257-70. PubMed ID: 17950513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.